About
BiotechBlog is managed by Yali Friedman.
Yali Friedman, Ph.D., is founder of thinkBiotech. His book, Building Biotechnology, is used as a course text in dozens of biotechnology programs. His other books include Best Practices in Biotechnology Education and Best Practices in Biotechnology Business Development.
Yali is also managing editor of the Journal of Commercial Biotechnology, a member of the editorial advisory board of the Journal of Medical Marketing and served on the Biotechnology Journal editorial advisory board. He is also a member of the board of directors and steering group of the Center for Policy on Emerging Technologies, serves on the science advisory board of Chakra Biotech, and has also served as a judge for the Biotech Humanitarian Award and the Maryland Incubator Company of the Year Award.
Yali also has strong exposure to leading issues in international biotechnology. He served as lead editorial consultant for Scientific American’s worldVIEW, a global biotechnology perspective profiling biotechnology industries and opportunities in 36 countries, and has been invited to participate in biotechnology industry development forums for countries such as Canada, Germany, the Philippines, and Turkey.
Yali teaches biotechnology management at the National Institutes of Health and regularly guest-lectures for other biotechnology education programs, and writes and talks on diverse topics such as biotechnology entrepreneurship, strategies to cope with a lack of management talent and capital when developing companies outside of established hubs, and new paradigms in technology-based economic development.
BiotechBlog is a product of Yali’s long history in biotechnology media. He created a Forbes “Best of the Web”-rated web site on the biotechnology industry for a NY Times company and managed it for many years. His other projects include the Student Guide to DNA Based Computers, sponsored by FUJI Television, and DrugPatentWatch.com, a pharmaceutical industry competitive intelligence service.


![[Bloglines]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/bloglines.png)
![[del.icio.us]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/delicious.png)
![[Digg]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/digg.png)
![[Facebook]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/facebook.png)
![[Google]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/google.png)
![[LinkedIn]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/linkedin.png)
![[Reddit]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/reddit.png)
![[StumbleUpon]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/stumbleupon.png)
![[Twitter]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/twitter.png)
![[Email]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/email.png)









































Comments on this entry are closed.